For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
We develop comprehensive strategies for treating and preventing life-threatening illnesses, no matter how complex. How? By integrating our deep scientific, epidemiological, medical, public health, and regulatory expertise with solutions that cover everything from medical feasibility assessment to trial management, pathogen surveillance, and market access.
Our infectious disease team is built upon the global experience and public health knowledge your project needs. Our expertise includes regulatory affairs, real-world evidence, epidemiology, genomics, pulmonology, cardiology, and all other relevant therapeutic areas across age groups. With this expertise, we optimize protocols and implement innovative trial designs to drive your research forward.
Our experts in infectious disease & vaccines
Our team has extensive global experience with viral indications that include COVID-19, SARS, H1N1, MERS, and Ebola, as well as influenza, RSV, HIV/AIDS, HSV, HPV, and hepatitis B and C.
We have specialized expertise in multi-drug-resistant infections, including cIA, cUTI, HAP/VAP, ABSSI, joint infections, and osteomyelitis.
We’ve done extensive work in preventing and treating COVID-19, influenza, RSV, pneumococcal and meningococcal infections, and dengue, including development experience with pandemic vaccines and with combination vaccines for pediatrics.
We offer access to a global network of critical care specialty centers, with particular expertise in sepsis indications, nosocomial infections, and hospital-based critical care studies.
We’ve developed a Long COVID Syndrome Program to address the continuing impact on these patients — working with sites, registries, and patients across therapeutic areas to streamline research. For these patients and their little-understood conditions, it’s more crucial than ever to listen to their voices, seating them at the head of the table to guide us toward meaningful outcomes. We also bring strong experience working on COVID-19 treatments, with recognition as a top-ranked CRO for COVID-19 clinical development services, according to the Life Science Strategy Group.
Our extensive vaccine experiences and capabilities help your trials thrive throughout the life of your program. We’ve developed regional pathogen surveillance programs, conducted global epidemiology research, and are involved in ongoing regional incidence tracking. We also use patient mapping, chart reviews, community outreach, and lab results to target future volunteers at their first point of medical contact.
We’ve developed methods for recruiting study participants ranging from neonates to geriatrics, with a global network of research sites that include vaccine centers, decentralized community outreach, outpatient clinics, hospitals, and critical-care specialty centers. This ensures you have access to the patients you need.
Our cross-functional expertise is integrated across all stages of development, from Phase I to Phase IV. Our deep understanding of the nuances of delivering trials for infectious disease is reflected in our operational excellence, which includes a specific focus on microbiological and clinical endpoints, as well as long-term surveillance and case event capture.
In addition to lab-based work that incorporates genomics, prognostic biomarkers, and state-of-the-art diagnostics, we bring extensive expertise in hospital-based and global trials for academic research, as well as research funded by third-party organizations like governments (BARDA, NIH, EMA) and grant providers.
Tap into our global public health team, which has experience facing crises like COVID-19, SARS, H1N1, MERS, and Ebola.
Access more patient segments, ranging from neonates to geriatrics and diverse populations.
Lean on our expertise as a top-ranked CRO for COVID-19 clinical development (Source: Life Sciences Strategy Group).
Navigate the nuances of your trial with our focus on long-term surveillance and microbiological and clinical endpoints.
Predict drug effects ahead of time and create efficiencies with advanced modeling and simulation.
Lean on our global clinical trial supplies & logistics expertise in vaccines, including importing and exporting.
Want to hear from our experts on the latest topics in infectious disease and vaccines? Visit our Insights Center to read, watch, and listen.